Tablet Dedusters Are Flexible and Efficient - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Tablet Dedusters Are Flexible and Efficient


Vertical tablet conveyors/dedusters have become an economical way to efficiently convey and dedust vitamin and nutraceutical tablets using a small footprint. The Kraemer KD60 series vertical vibratory conveyor uses gentle vibration to dedust and convey the product quietly (less than 70 db) upward in a spiral along a smooth, perforated surface (0.3 µm Ra surface roughness). A window gives full view and access to see the tablet movement up the helix.
 
Inlet and outlet orientation is adjusted easily without tools, and the stand height adjusts to meet press requirements. The all stainless-steel construction, cGMP design, and tool-less disassembly allow for easy cleaning in full compliance with FDA standards. The C820 controller with integrated acceleration sensor allows for a constant flow of tablets under varying tablet loads. The conveyor/deduster can be configured with an integral metal detector.

Source: Kraemer US

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
35%
Breakthrough designations
12%
Protecting the supply chain
35%
Expedited reviews of drug submissions
12%
More stakeholder involvement
6%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
NIH Translational Research Partnership Yields Promising Therapy
Clusters set to benefit from improved funding climate but IP rights are even more critical
Supplier Audit Program Marks Progress
FDA, Drug Companies Struggle with Compassionate Use Requests
USP Faces New Challenges

Click here